Kuzuya T, Nakagawa S, Satoh J, et al . Report of the committee on the classification and diagnostic criteria of diabetes mellitus[J]. Diabetes Res Clin Pract,2002,55 (1) :66.
Barbara Mlinar, Janja Marc, Andrej Jane, et al. Molecular mechanisms of insulin resistance and associated diseases [J]. Clinica Chimica Acta, 2007, 375 :21.
[4]
DeFronzo R A. Pathogenesis of type 2 diabetes mellitus [J]. Med Clin North Am, 2004, 88:787.
[5]
徐冲,徐国恒.糖皮质激素与脂肪代谢和胰岛素抵抗[J].生理科学进展, 2009,40(1):19.
[6]
Gathercole L L, Bujalska I J, Stewart P M, et al. Glucocorticoid modulation of insulin signaling in human subcutaneousadipose tissue [J]. Clin Endocrinol Metab, 2007, 92 : 4332.
[7]
Pickup J C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes [J]. Diabetes Care, 2004,27(3):813.
Kudolo G B. The effect of 3-month ingestion of Ginkgo biloba extract ( EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus[J]. J Clin Pharmacol, 2001, 41 (6): 600.
Baur J A, Pearson K J, Price N L, et a1. Resveratrol improves health and survival of mice on a high-calorie diet[J]. Nature, 2006, 444(7117):337.
[28]
Lagouge M, Argmann C, Gerhart-Hines Z, et aI. Resveratrol improves mitochondria1 function and protects against metabolic disease by activating SIRT1 and PGC-1alpha[J]. Cell, 2006,127(6):1109.
[29]
Sun C, Zhang F, Ge X, et a1. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B[J] .Cell Metab, 2007,6(4):307.